Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Assets: 2019-2025

Historic Return on Assets for Autolus Therapeutics (AUTL) over the last 5 years, with Sep 2025 value amounting to -0.33%.

  • Autolus Therapeutics' Return on Assets changed negligibly% to -0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.33%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -0.38% for FY2024, which is 10.00% up from last year.
  • As of Q3 2025, Autolus Therapeutics' Return on Assets stood at -0.33%, which was down 4.72% from -0.31% recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Return on Assets registered a high of -0.27% during Q2 2024, and its lowest value of -143.17% during Q3 2021.
  • In the last 3 years, Autolus Therapeutics' Return on Assets had a median value of -0.32% in 2024 and averaged -0.34%.
  • As far as peak fluctuations go, Autolus Therapeutics' Return on Assets crashed by 14,269bps in 2021, and later skyrocketed by 14,272bps in 2022.
  • Autolus Therapeutics' Return on Assets (Quarterly) stood at -127.77% in 2021, then surged by 12,737bps to -0.39% in 2022, then dropped by 14bps to -0.53% in 2023, then climbed by 26bps to -0.27% in 2024, then remained steady at -0.33% in 2025.
  • Its Return on Assets was -0.33% in Q3 2025, compared to -0.31% in Q2 2025 and -0.31% in Q1 2025.